Advances in automated cell washing and concentration
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The successful commercialization of cell therapies requires thorough planning and consideration of product quality, cost and scale of the manufacturing process. The implementation of automation can be central to a robust and reproducible manufacturing process at industrialized scales. There have been a number of wash-and-concentrate devices developed for cell manufacturing. These technologies have arisen from transfusion medicine, hematopoietic stem cell and biologics manufacturing where operating mechanisms are distinct from manual centrifugation. This review describes the historical origin and fundamental technologies underlying each currently available wash-and-concentrate device as well as their relative advantages and disadvantages in cell therapy applications. Understanding the specific attributes and limitations of these technologies is essential to optimizing cell therapy manufacturing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical manufacturing of CAR T cells: foundation of a promising therapy
Wang, X., & Rivière, I. (2016) · Molecular Therapy - Oncolytics · doi:10.1038/mto.2016.15 · Cited by 637
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
Stroncek, D. F., Lee, D. W., Ren, J., Sabatino, M., Highfill, S., Khuu, H., Shah, N. N., Kaplan, R. N., Fry, T. J., & Mackall, C. L. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1160-5 · Cited by 80
Harrison, R. P., Ruck, S., Medcalf, N., & Rafiq, Q. A. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.07.005 · Cited by 72
End-to-End Platform for Human Pluripotent Stem Cell Manufacturing
Pandey, P. R., Tomney, A., Woon, M. T., Uth, N., Shafighi, F., Ngabo, I., Vallabhaneni, H., Levinson, Y., Abraham, E., & Friedrich Ben-Nun, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010089 · Cited by 42
Kikuchi, T., Kino-oka, M., Wada, M., Kobayashi, T., Kato, M., Takeda, S., Kubo, H., Ogawa, T., Sunayama, H., Tanimoto, K., et al. (2018) · Regenerative Therapy · doi:10.1016/j.reth.2018.08.004 · Cited by 37
Cited by
Promises and challenges of a decentralized CAR T-cell manufacturing model
Shah, M., Krull, A., Odonnell, L., de Lima, M. J., & Bezerra, E. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1238535 · Cited by 77
Cost-effective strategies for CAR-T cell therapy manufacturing
Abdo, L., Batista-Silva, L. R., & Bonamino, M. H. (2025) · Molecular Therapy Oncology · doi:10.1016/j.omton.2025.200980 · Cited by 54
Syed, F., El Fakih, R., Alahmari, A. D., Ali, A. S. O., & Aljurf, M. (2022) · Hematology/Oncology and Stem Cell Therapy · doi:10.56875/2589-0646.1048 · Cited by 18
Metadata
- Authors
- Li, A., Kusuma, G. D., Driscoll, D., Smith, N., Wall, D. M., Levine, B. L., James, D., & Lim, R.
- Venue
- Cytotherapy
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 23
- Issue
- 9
- Pages
- 774-786
- ISSN
- 1465-3249 (ISSN-L)
- OpenAlex
- W3165329193
- Cited by
- 49
- References
- 5
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advances in automated cell washing and concentration. https://app.cochat.ai/papers/10.1016/j.jcyt.2021.04.003
- The paper
- Li, A., Kusuma, G. D., Driscoll, D., Smith, N., Wall, D. M., Levine, B. L., James, D., & Lim, R. (2021). Advances in automated cell washing and concentration. Cytotherapy. https://doi.org/10.1016/j.jcyt.2021.04.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.